MÆDICA - a Journal of Clinical Medicine Logo
  • Home
  • Profile
  • Standards
    • Types of articles
    • Instructions for authors
    • Editing rules (peer-review protocol)
    • Official Journal’s protocols
  • Editorial Council
  • Peer-review TEAM
  • How to
  • Menu

Author archives

  • About
  • Latest Posts

Dragos VINEREANU

Latest posts by Dragos VINEREANU (see all)

  • Left Ventricular Systolic Function in Pregnant Women with Inherited Thrombophilia - October 17, 2019
  • The Romanian National Registry of non-ST Elevation Acute Coronary Syndromes – Design and Rationale - October 17, 2019
  • Cardiac Memory – from Theory to Clinical Practice - July 19, 2019

Articles signed on MÆDICA, JCM:

Left Ventricular Systolic Function in Pregnant Women with Inherited Thrombophilia

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 14, No. 3, 2019
CNCSIS - CMR - B+ OBBCSSR

Members Area


Left Ventricular Systolic Function in Pregnant Women with Inherited Thrombophilia

Livia Florentina TRASCA, Elena POENARU, Natalia PATRASCU, Ramona BRUJA, Octavian MUNTEANU, Monica CIRSTOIU and Dragos VINEREANU

ABSTRACT

Objectives: The impact of the gestational changes on left ventricular contractility is not clearly defined. Our aim was to evaluate the subtle changes of left ventricular systolic function during pregnancy, assessed by new echocardiographic techniques, in a population tested for inherited thrombophilia.
Material and methods: Eighty seven consecutive pregnant women, with a mean age of 32±4 years, genetically tested for inherited thrombophilia (22 with thrombophilic mutations and risk of thrombosis and 65 without significant mutations, considered as the control group) were included. All participants had four clinical and echocardiographyc visits: three during pregnancy (one in each trimester) and the forth six months after giving birth. Left ventricular (LV) systolic function was assessed from ejection fraction (EF) by 2D and 3D echocardiography, mitral annular velocities by tissue Doppler, and strain rate by 2D speckle tracking.
Outcomes: There were no differences between groups for any of the echo parameters at each of the four visits. Comparing the third visit with the first one, all parameters of LV systolic function had significantly lower values at the end of pregnancy; EF decreased from 58% to 55% (2D echo), from 60% to 56% (3D TomTec), and from 58% to 55% (Auto4DLVQ), with p<0.001 for all three methods. Moreover, strain assessed by speckle traking decreased during pregnancy, with no differences between groups. In addition to this, mitral annular velocities obtained by tissue Doppler assessment decreased during the gestational period, with no differences between groups. At six months after giving birth, all values were normalized.
Conclusion: During pregnancy, LV contractility has a slight decrease, with no criteria of systolic dysfunction. Thrombophilic mutations, with correct anticoagulant treatment, has no impact on LV systolic function.
Keywords: pregnancy, contractility, thrombophilia

Full text | PDF

The Romanian National Registry of non-ST Elevation Acute Coronary Syndromes – Design and Rationale

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 14, No. 3, 2019
CNCSIS - CMR - B+ OBBCSSR

Members Area


The Romanian National Registry of non-ST Elevation Acute Coronary Syndromes – Design and Rationale

Alexandru George COTOBAN, Cristian Alexandru UDROIU and Dragos VINEREANU

ABSTRACT

Introduction: Non-ST segment elevation acute coronary syndromes (NSTE-ACS) form a large part of the number of annual emergency admissions in the Cardiology Departments in Romania, representing a significant burden on the health care system resources. The European Society of Cardiology (ESC) guidelines for the diagnosis and treatment of NSTE-ACS patients represent ideal standards, which are difficult to implement, given the significant differences in the socio-economic climates of the various European Union countries, as the access to modern reperfusion techniques for NSTE-ACS patients, including Romania, is usually suboptimal.
Objectives: The evaluate the current implementation state of the ESC recommended protocols for the diagnosis and treatment of NSTE-ACS patients in Romania. There are no data regarding the number of patients who benefit from modern revascularization techniques, the time intervals between symptom onset, positive diagnosis and revascularization procedures, and the impact of these strategies on in-hospital and one-year mortality.
Materials and methods: We support the development of an online National Registry of NSTE-ACS patients, in which data obtained from the in-hospital medical records of patients undergoing invasive management will be prospectively recorded. The platform will initially be accessible to 11 interventional centers, and will include patients diagnosed and treated according to local protocols. Patient status at one year after the acute event will also be recorded. The Registry will eventually be accessible to any center in Romania caring for NSTE-ACS patients. The recorded variables will be based on those with a significant impact on the time from symptom onset to the positive diagnosis, type of clinical presentation, appropriate treatment initiation and the type of applied treatment.
Expected outcomes: Local clinical expertise, the number of treated patients and center-level technical barriers are expected to significantly influence the reported diagnostic and therapeutic measures. The performance of the various local in-hospital guidelines and transfer protocols between non-interventional and interventional centers will be analyzed, based on which recommendations and objectives can be defined in order to optimize the ESC guidelines implementation.
Conclusion: The National Registry of non-ST elevation acute coronary syndromes will provide an essential tool that facilitates the implementation of optimal ESC guideline-driven diagnostic and treatment measures, by adapting its recommendations to the socio-economic status in Romania and ensuring the best possible outcomes for the NSTE-ACS patient.
Keywords: ischemic heart disease, non-ST elevation acute coronary syndromes, unstable angina, myocardial infarction, registry, Romania

Full text | PDF

Cardiac Memory – from Theory to Clinical Practice

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 14, No. 2, 2019
CNCSIS - CMR - B+ OBBCSSR

Members Area


Cardiac Memory – from Theory to Clinical Practice

Maria-Claudia-Berenice SURAN, Calin SILISTE and Dragos VINEREANU

ABSTRACT

Cardiac memory (CM) is defined as changes in T wave polarity and vector that appear after cessation of a period of abnormal ventricular depolarization of various causes.
The mechanisms responsible for CM development are initiation by local stretch, requiring myocardial contraction, followed by a cascade of intracellular signals that lead to a reduction in repolarization currents, especially Ito.
In practice, CM is a frequently encountered ECG phenomenon, especially in patients with intermittent ventricular pacing, and knowledge of the ECG pattern of CM may help quick differential diagnosis from ischemia. While CM is most often a benign finding, in rare cases, association between CM and severe bradycardia or other factors for QT prolongation may be pro-arrhythmic and requires emergency care.
Keywords: cardiac memory, T wave

Full text | PDF

Regional Mechanical Changes Assessed by 2D Speckle-Tracking Longitudinal Strain do not Parallel Electrical Post-Pacing Cardiac Memory

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 13, nr. 3, 2018
CNCSIS - CMR - B+ OBBCSSR

Members Area


Regional Mechanical Changes Assessed by 2D Speckle-Tracking Longitudinal Strain do not Parallel Electrical Post-Pacing Cardiac Memory

Maria-Claudia-Berenice SURAN, Andrei-Dumitru MARGULESCU, Ramona BRUJA, Calin SILISTE and Dragos VINEREANU

ABSTRACT

Background. Cardiac memory (CM) refers to persistent T-wave changes that appear after cessation of a period of abnormal ventricular activation, such as ventricular pacing. Prior animal studies using tagged magnetic resonance imaging have suggested that CM is associated with prolonged action potential duration and increased strain of late-activated myocardial segments.
Objective. The aim of the present study is to determine whether CM induced by ventricular pacing in human subjects is accompanied by regional mechanical changes in late-activated myocardial segments, assessed by left ventricular (LV) longitudinal strain (peak LS) and time-to-peak longitudinal strain (TTP-LS), using 2D-speckle tracking echocardiography (2DSE).
Material and methods. We included 20 patients (16 women, age 71±11 years), with DDD pacemakers and with normal AV conduction and QRS/T morphology at baseline. CM was induced by DDD pacing with a short AV delay. ECGs and 2DSE were performed before pacing (baseline), at peak CM (immediately after two weeks of pacing), and at CM washout (4 weeks after cessation of pacing). We measured by echocardiography: left ventricular (LV) ejection fraction, LV diastolic function (E, A, E/E’), peak LS and TTP-LS for the earliest (i.e. adjacent to the pacing site) and latest (i.e. latest-activated during ventricular pacing) segments, using an 18-segment LV model.
Results. All patients had electrical (ECG) CM changes, which disappeared by CM washout. LV global systolic and diastolic functions, as well as regional LS (peak LS for both the latest and earliest activated segments) were similar between evaluations. TTP for the latest and earliest activated segments, as well as mean TTP-LS, increased from baseline to peak CM, but did not decrease at CM washout. The dispersion of TTP-LS was not changed.
Conclusion. These results suggest that regional mechanical changes, as can be assessed by 2DSE longitudinal strain, do not overlap electrical CM.
Keywords: 2-dimensional strain, 2DSE, echocardiography, cardiac memory.

Full text | PDF

Advanced Atherosclerosis with Leriche Syndrome, in a Patient with Carney Complex

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 13, nr. 2, 2018
CNCSIS - CMR - B+ OBBCSSR

Members Area


Advanced Atherosclerosis with Leriche Syndrome, in a Patient with Carney Complex

Ionela-Simona VISOIU, Maria Cristina CONSTANTINESCU, Natalia PATRASCU, Claudiu Ionut STOICESCU, Bogdan DOROBAT, Radu BREZEANU, Cristina ANTON, Dragos VINEREANU and Mircea CINTEZA

ABSTRACT

Carney complex (CNC) is a rare autosomal dominant syndrome. Spotty skin pigmentation is the major clinical manifestation of CNC, followed by cardiac myxomas, benign tumors that usually present with features from the classical triad of obstructive cardiac, embolic and non-specific constitutional symptoms (NCS). NCS are caused by the overproduction of interleukin-6 (IL-6), a pro-inflammatory cytokine which mediates the induction of intercellular adhesion molecule 1 (ICAM-1) and promotes endothelial dysfunction and atherosclerosis. Thus, myxomas may be directly linked to an increased risk of atherosclerotic events.
We report here a case of a 74-year-old woman with left atrial myxoma, skin pigmentary abnormalities, thyroid disorder and extensive atherosclerosis, with non-embolic occlusion of infrarenal abdominal aorta.
Keywords: Carney complex, critical limb ischemia, Leriche syndrome, cardiac myxoma, atherosclerosis, autoimmune thyroid disorder

Full text | PDF

Catecholaminergic Polymorphic Ventricular Tachycardia – Looking to the Future

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 12, nr. 4, 2017
CNCSIS - CMR - B+ OBBCSSR

Members Area


Catecholaminergic Polymorphic Ventricular Tachycardia – Looking to the Future

Andreea Elena VELCEA, Calin SILISTE and Dragos VINEREANU

ABSTRACT

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inheritable cardiac disorder, characterized by polymorphic ventricular tachycardia (PVT) or bidirectional ventricular tachycardia, triggered by adrenergic stress, and manifested most frequently as syncope or sudden cardiac death. The disease has a heterogeneous genetic basis, with mutations in the genes encoding the ryanodine and calsequestrin channels accounting for the majority of cases.
The diagnosis of CPVT is established in individuals with polymorphic ventricular premature beats, PVT or bidirectional ventricular tachycardia documented during exercise or adrenergic stress, who have a structurally normal heart and normal resting ECG. Genetic testing completes the diagnosis, but is limited by the fact that, to date, about one third of cases are genotype-unknown.
Treatment strategies have improved as the knowledge of the disease has evolved, and several therapeutic options are now available. They include pharmacologic measures (especially non-selective beta-blockers and flecainide), but also more complex interventions, such implantation of internal cardiac defibrillators and left cardiac sympathetic denervation.
There are many unknowns to CPVT, but one that is essential to clinical practice is risk stratification, which will aid in a more targeted treatment of these patients. This goal is to be achieved by creating large patient registries and bio-banks, and ultimately by incorporating both clinical and genetic data into a risk stratification score.
Keywords: cathecolaminergic polymorphic ventricular tachycardia, bidirectional tachycardia, sudden cardiac death, genetic mutations

Full text | PDF

Healing a Broken Heart: a Case Report of Left Ventricular Free Wall Rupture and Review of the Literature

SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 11, nr. 4, 2016 CNCSIS - CMR - B+ OBBCSSR

Members Area


Healing a Broken Heart: a Case Report of Left Ventricular Free Wall Rupture and Review of the Literature

Roxana Oana DARABONT, Alexandru VASILESCU and Dragos VINEREANU

ABSTRACT

The occurrence of left ventricular free wall rupture in acute myocardial infarction decreased with the extent of interventional procedures of reperfusion, but it is still encountered in 1-2% of these patients. We are presenting the case of a 58 years old male with left ventricular free wall rupture occurred as a late complication of an inferior-lateral ST-elevated myocardial infarction. The aim of this case report is to underline the main clinical features, the diagnostic value of the echocardiographic exam and the importance of early surgical intervention in a rare, but very dangerous condition, with persistent high mortality rates. In this context, we will review the current prevalence, clinical forms and prediction factors of left ventricular free wall rupture.
Keywords: Free wall rupture of the left ventricle, acute myocardial infarction, cardiogenic shock

Full text | PDF

Telocytes – a Hope for Cardiac Repair after Myocardial Infarction

SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 11, nr. 4, 2016 CNCSIS - CMR - B+ OBBCSSR

Members Area


Telocytes – a Hope for Cardiac Repair after Myocardial Infarction

Ruxandra DRAGOI GALRINHO, Catalin Gabriel MANOLE and Dragos VINEREANU

ABSTRACT

Cardiovascular diseases, particularly myocardial infarction, remain the leading cause of morbidity and mortality worldwide, even though pharmacological and interventional therapies improved significantly in the last years. Moreover, despite encouraging results of cell - based therapies in experimental myocardial infarction models, clinical trials showed inconsistent and modest efficiency. Therefore the next step should be the revealing of a new cell type, capable of regenerating the damaged myocardium.
Telocytes (TCs), a relatively new type of interstitial cells, were described few years ago and are credited with important roles in regenerative therapies.
In this paper we review their most important characteristics and functions, showing the evidences of their potential role in cardiac repair and regeneration.
Our research leads to the conclusion that TCs might be a novel target for therapeutic strategies in myocardial infarction.
Keywords: Myocardial infarction, telocytes, regenerative therapies

Full text | PDF

The Assessment of Subclinical Cardiovascular Dysfunction in Treated Rheumatoid Arthritis

SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 11, nr. 4, 2016 CNCSIS - CMR - B+ OBBCSSR

Members Area


The Assessment of Subclinical Cardiovascular Dysfunction in Treated Rheumatoid Arthritis

Stefania L. MAGDA, Raluca I. MINCU, Maria FLORESCU, Andrea O. CIOBANU, Gabriela F UDREA, Mircea CINTEZA and Dragos VINEREANU

ABSTRACT

Background and purpose: Rheumatoid arthritis (RA) causes frequently cardiovascular complications, probably determined by early atherosclerosis in connection to chronic systemic inflammation. Purpose of our study was to assess subclinical cardiac and vascular dysfunction, and to evaluate the mechanisms of ventriculo-arterial interaction, in patients with correctly treated RA vs. normal subjects.
Methods: We evaluated 46 subjects (55±10 years, 2 men): 29 patients with seropositive treated RA (mean duration of 11±9 years), without documented cardiovascular or pulmonary disease, and 17 control subjects, matched for age, sex, and distribution of conventional major risk factors. All RA patients were under long-term treatment (more than 6 months) with Methotrexat + Sulfasalasine (22 patients) or Methotrexat + Sulfasalasine + Infliximab (7 patients). We determined biomarkers of inflammation (P-selectin, interleukines 1, 6, 10, 18, seric amiloid A, α-TNF, γ-interferon, C-reactive protein, anti-oxidated LDL antibodies), myocardial fibrosis (β-crosslaps) and ventricular overload (BNP). We assessed the parameters of cardiac function by standard and tissue Doppler echocardiography, intima-media thickness and arterial stiffness by “e-tracking” and “wave intensity analysis” (at the level of the right carotid artery), endothelial function by flow mediated dilation (FMD), and carotid-femoral pulse wave velocity by the Complior method.
Results: Biological parameters of inflammation, markers of myocardial fibrosis and of ventricular overload were not different between the 2 study groups. Also, parameters of subclinical cardiac and vascular function were similar between the two groups. RA patients had subclinical RV dysfunction, correlated to the duration of the disease. They also tended to have higher values of systolic pulmonary artery pressure than normals.
Conclusion: Correctly treated patients with RA, with controlled systemic inflammation, have normal LV, endothelial and arterial function. However, in the absence of documented pulmonary disease, they do have subclinical RV dysfunction, correlated with the duration of disease. This suggests an intrinsic RV myocardial involvement but, since pulmonary artery pressure was also higher, a secondary mechanism might be also involved.

Full text | PDF

Cardiovascular Dysfunction in Multiple Sclerosis

SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 10, nr. 4, 2015 CNCSIS - CMR - B+ OBBCSSR

Members Area


Cardiovascular Dysfunction in Multiple Sclerosis

Raluca Ileana MINCU, Lucia Stefania MAGDA, Maria FLORESCU, Andreea VELCEA, Sorina MIHAILA, Diana MIHALCEA, Bogdan O. POPESCU, Adela CHIRU, Cristina TIU, Mircea CINTEZA and Dragos VINEREANU

ABSTRACT

Multiple sclerosis (MS) is a chronic neurological condition, characterized by recurrent episodes of inflammation and demyelination of the central nervous system called relapsing-remitting episodes, and continuous axonal degeneration that leads to irreversible progressive invalidity.

Patients with multiple sclerosis present a higher mortality rate compared to the general population, and the excess of mortality may be explained by the increased cardiovascular risk and occurrence of cardiovascular disease. However, the exact pathways to cardiovascular dysfunction are not yet completely elucidated.

This review focuses on the most important mechanisms of cardiovascular dysfunction in MS, such as the cardiomyocite structure alteration, the cardiovascular autonomous nervous system dysfunction, physical invalidity, oxidative stress and endothelial dysfunction, as well as the impact of cardiovascular risk factors in MS.

The latest evidence about therapeutic approaches for MS, such as immunomodulatory treatment, vitamin D supplementation and statins are also discussed.

There is little knowledge about the cardiovascular dysfunction in MS, and further research is required to improve the understanding of these complex mechanisms.

Keywords: multiple sclerosis, cardiovascular dysfunction, immunonodulatory treatment

Full text | PDF

Post navigation

1 2 3 Next »


plic-mail[email protected]

 Terms and conditions

© MÆDICA - a Journal of Clinical Medicine - All rights reserved